Abstract:Objective: To investigate the effect and mechanisms of KPT-330 on cell apoptosis of human leukemia cells. Methods: CCK-8 assay was used to quantify the growth inhibition of cells after exposure to KPT-330 for 24 hours. Fluorescence microscope was used to observe the morphological change of leukemia cell when treated with KPT330 for 24 hours. Annexin V/propidium iodide staining followed by flow cytometric analysis was used to detect apoptosis of leukemia cells. Then Western blot was used to detect the expression level of CRM1 and the activation of apoptosis related protein Caspase-9、Caspase-3 and PARP level. LncRNA microarray was used to analyze the differentially expressed genes from the cluster analyses. Results: The inhibition of cell proliferation of leukemia cells was in a dose-dependent manner and KPT-330 treatment induced expression of CRM1 down-regulated .Abnormal cells were observed under fluorescence microscopy. Cell apoptosis, cell cycle and activation of apoptosis markers demonstrates that KPT-330 induced apoptosis in leukemia cells. LncRNA microarray analysis showed differently expressed mRNAs and lncRNAs in KPT-330 treated HL-60 cells compared with control group. Molecular function analysis showed that KPT-330 induced apoptosis in leukemia cells partially related with Glutathione metabolism and Toll-like receptor signaling pathway. Conclusion: In this study, KPT-330 treatment resulted in inhibition of cell proliferation and induction of apoptosis in leukemia cells. LncRNA microarray analysis showed differentially expressed genes and lncRNAs in KPT-330 treated HL-60 cells and we demonstrated that KPT-330 induced apoptosis in leukemia cells partially related with Glutathione metabolism and Toll-like receptor signaling pathway. These results may provide new clue about molecular mechanism of KPT-330 induced apoptosis; however, underlying details will be required to determine further. Taken together, our findings suggest that for the first time that KPT-330 may act as new candidate's drug for leukemia. Disclosures No relevant conflicts of interest to declare.

Induction Of Apoptosis Of Human B-Cll And All Cells By A Novel Retinoid And Its Nonretinoidal Analog

Induction Of Apoptosis In Retinoid-Refractory Acute Myelogenous Leukemia By A Novel Ahpn Analog

[A Novel Retinoid CD437 Induces Apoptosis of Human Epidermoid Carcinoma A431 Cells].

Apoptosis induced by synthetic retinoic acid CD437 on human melanoma A375 cells involves RIG-I pathway

Molecular Determinants of AHPN (Cd437)-Induced Growth Arrest and Apoptosis in Human Lung Cancer Cell Lines

Apoptosis Induction In Cancer Cells By A Novel Analogue Of 6-[3-(1-Adamantyl)-4-Hydroxyphenyl]-2-Naphthalenecarboxylic Acid Lacking Retinoid Receptor Transcriptional Activation Activity

Induction of Apoptosis and Down-Regulation of Bcl-XL in Cancer Cells by a Novel Small Molecule, 2[[3-(2,3-Dichlorophenoxy)propyl]amino]ethanol.

Bh3 Mimetic Abt-737 Induces Apoptosis in Cd34(+) Acute Myeloid Leukemia Cells and Shows Synergistic Effect with Conventional Chemotherapeutic Drugs

Novel indole retinoid derivative induces apoptosis and cell cycle arrest and modulates AKT and ERK signaling in HL-60 cells

[New Retinoid SX-116 Induces Apoptosis of Acute Promyelocytic Leukemia Cell Line NB4]

Bcl-2 Antisense Oligodeoxynucleotide Enhances Araninosyl Cytosine-Induced Apoptosis of Primary Leukemia Cells

Novel Bcl‐2 Inhibitors: Discovery and Mechanism Study of Small Organic Apoptosis‐Inducing Agents

Molecular Mechanism Analysis the Apoptosis of Leukemia Cells Induced by CRM1 Selective Inhibitor KPT-330

A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway

Induction Of Cell Cycle Arrest And Apoptosis By A Combined Treatment With 13-Cis-Retinoic Acid, Interferon-Alpha 2a, And Alpha-Tocopherol In Squamous Cell Carcinoma Of The Head And Neck

Preclinical study of apoptosis of B-NHL cell lines induced by anti-CD20 monoclonal antibody]

Cell Permeable Bcl-2 Binding Peptides: A Chemical Approach to Apoptosis Induction in Tumor Cells

Apoptosis Induction of ZBB-006, a Novel Synthetic Diterpenoid, in the Human Hepatocellular Carcinoma Cell Line HepG2 in Vitro and in Vivo.

A Novel Water-Soluble Benzothiazole Derivative BD926 Triggers ROS-mediated B Lymphoma Cell Apoptosis Via Mitochondrial and Endoplasmic Reticulum Signaling Pathways.

The molecular mechanism of a novel derivative of BTO-956 induced apoptosis in human myelomonocytic lymphoma cells

Induction of G2/M Phase Arrest and Apoptosis by A Novel Enediyne Derivative, Thda, in Chronic Myeloid Leukemia (K562) Cells